Strategies to Enhance Drug Permeability across Biological Barriers
Overcoming biological barriers is a significant challenge in drug development, and recent advancements in drug delivery systems and technologies offer promising solutions. This Special Issue highlights the innovative approaches and techniques being used to improve drug permeability and absorption, a...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_100863 | ||
| 005 | 20230623 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230623s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-7462-2 | ||
| 020 | |a 9783036574639 | ||
| 020 | |a 9783036574622 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-7462-2 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a KNDP |2 bicssc | |
| 100 | 1 | |a Wen, Jingyuan |4 edt | |
| 700 | 1 | |a Huang, Yuan |4 edt | |
| 700 | 1 | |a Wen, Jingyuan |4 oth | |
| 700 | 1 | |a Huang, Yuan |4 oth | |
| 245 | 1 | 0 | |a Strategies to Enhance Drug Permeability across Biological Barriers |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (278 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Overcoming biological barriers is a significant challenge in drug development, and recent advancements in drug delivery systems and technologies offer promising solutions. This Special Issue highlights the innovative approaches and techniques being used to improve drug permeability and absorption, as well as their potential impact on a wide range of therapeutic goals. These advancements being made in drug delivery and permeability offer exciting possibilities to improve patient outcomes. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmaceutical industries |2 bicssc | |
| 653 | |a brain tumor | ||
| 653 | |a glioma | ||
| 653 | |a drug delivery | ||
| 653 | |a injection | ||
| 653 | |a intra-arterial | ||
| 653 | |a chemotherapy | ||
| 653 | |a targeted therapy | ||
| 653 | |a immunotherapy | ||
| 653 | |a nanoparticles | ||
| 653 | |a treatment | ||
| 653 | |a blood-brain barrier modulation | ||
| 653 | |a tight junction | ||
| 653 | |a active efflux | ||
| 653 | |a transcytosis | ||
| 653 | |a oligonucleotide | ||
| 653 | |a lipid conjugates | ||
| 653 | |a LNP | ||
| 653 | |a delivery | ||
| 653 | |a cholesterol | ||
| 653 | |a fatty acid | ||
| 653 | |a tocopherol | ||
| 653 | |a squalene | ||
| 653 | |a intranasal | ||
| 653 | |a nose-to-brain | ||
| 653 | |a CNS | ||
| 653 | |a nanocarriers | ||
| 653 | |a niosomes | ||
| 653 | |a catechin | ||
| 653 | |a dermal delivery | ||
| 653 | |a antioxidant activity | ||
| 653 | |a oxidative stress | ||
| 653 | |a skin barrier | ||
| 653 | |a penetration | ||
| 653 | |a cellular uptake | ||
| 653 | |a focused ultrasound | ||
| 653 | |a blood-brain barrier opening | ||
| 653 | |a therapeutic agent delivery | ||
| 653 | |a ultrasound parameters | ||
| 653 | |a ultrasound safety | ||
| 653 | |a review | ||
| 653 | |a lung metastasis | ||
| 653 | |a targeting | ||
| 653 | |a colorectal cancer | ||
| 653 | |a liposome | ||
| 653 | |a immunogenicity | ||
| 653 | |a CRISPR-Cas9 | ||
| 653 | |a blood-brain barrier | ||
| 653 | |a intestinal epithelial barrier | ||
| 653 | |a drug permeability | ||
| 653 | |a wound healing | ||
| 653 | |a natural products | ||
| 653 | |a advanced delivery | ||
| 653 | |a traditional medicine | ||
| 653 | |a alternative medicine | ||
| 653 | |a camptothecin | ||
| 653 | |a metastasis | ||
| 653 | |a mitochondria | ||
| 653 | |a 2-(dimethylamino) ethyl methacrylate | ||
| 653 | |a dissolution | ||
| 653 | |a absorption | ||
| 653 | |a inhalation | ||
| 653 | |a dry powders | ||
| 653 | |a fine particle dose | ||
| 653 | |a anxiety | ||
| 653 | |a blood-brain barrier | ||
| 653 | |a brain bioavailability | ||
| 653 | |a depression | ||
| 653 | |a drug molecule functionalization | ||
| 653 | |a nanoemulsions | ||
| 653 | |a nanosystems | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7326 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/100863 |7 0 |z DOAB: description of the publication |